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ABSTRACT 
Objective: This study aimed to establish the anti-inflammatory potential of macroalgae from Baja California Sur, Mexico.  
Methods: The anti-inflammatory activity of the extracts from 10 macroalgae species was evaluated in vitro and in vivo. Dichloromethane, ethanolic, 
and aqueous extracts were obtained from each species. The criteria used to determine anti-inflammatory activity included 1) the membrane 
protection of human red blood cells (HRBCs) against hemolysis induced by hypotonicity, 2) the inhibition of heat-induced protein denaturation 
(IDP), and 3) the inhibition of mouse ear edema and the myeloperoxidase (MPO) enzyme. 
Results: The dichloromethane extracts of Gracilaria vermiculophylla and Opuntiella californica were the most active, both in vitro and in vivo. These 
extracts resulted in values of HRBC membrane protection above 95%, which were similar to those obtained with diclofenac sodium. And reduce the 
inflammation with edema inhibition percentage up to 60 % while the control indomethacin was able to inhibit edema by 82.3 %. 
Conclusion: The bioprospection of several macroalgae species from Bahía de La Paz, Mexico, allowed the identification of two species with 
promising anti-inflammatory activity. Gracilaria vermiculophylla showed interesting topical anti-inflammatory effects and a profile of compounds 
(flavonoids and terpenes) that may contribute to the potential biological properties of this seaweed. This study represents the first report of the 
anti-inflammatory potential of O. californica. 
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INTRODUCTION 
Inflammation is a response of live tissues to injury, infection, or 
irritation. Lysosomal enzymes are released during the inflammatory 
response, leading to a variety of disorders that result in tissue injury due 
to macromolecule damage and membrane lipid peroxidation, which are 
assumed to be partly responsible for certain pathological conditions, 
such as heart attacks or rheumatoid arthritis. In recent years, chronic-
degenerative diseases involving various inflammatory processes have 
displaced infectious diseases as the leading causes of death worldwide 
[1]. Anti-inflammatory treatments involve the use of steroidal and non-
steroidal drugs. Glucocorticoids like cortisol, which are steroidal, inhibit 
the transcription of proinflammatory genes and suppress the immune 
response [2]. On the other hand, non-steroidal agents (e. g., diclofenac 
sodium) suppress the activity of the cyclooxygenase (COX) enzyme. 
However, the use of these agents has been associated with 
gastrointestinal complications and renal insufficiency [3]. 
The high incidence of chronic diseases associated with inflammation 
and the adverse effects associated with many commonly used drugs 
have guided research efforts to identify new sources, active principles 
and structures that are both highly effective and able to safely control 
the harmful effects of inflammation. Marine ecosystem contains more 
than 80% of the plant and animal species on the planet, which have 
evolved various adaptive abilities to cope with the continual stress 
present in their environmental. This has allowed researchers to tap 
into seemingly inexhaustible marine sources for the development of 
agents with diverse biopharmaceutical applications [4]. 
In this context, macroalgae have been reported to produce 
secondary metabolites that can be used to either prevent 
inflammation or protect cells from damage due to inflammatory 
reactions. Macroalgae constitute a natural source of active 
compounds with structural characteristics that confer highly 
effective pharmacological properties. The biological activities of 
macroalgal extracts have different mechanisms of action, including 
free radical sequestration, electron donation and acceptance, 
phospholipase A2 or DNA polymerase inhibition, and the formation 
and/or release of prostaglandins and leukotrienes [5-7]. 
Studies on the pharmacological potential of the algal resources from 
the Baja California peninsula are scarce; however, some evidence of 
the potential of these resources has been collected. For example, in 
1974, a group of researchers on board the oceanographic vessel Alpha 
Helix ventured into the Mexican Pacific and the Gulf of California in 
search of antibacterial, cytotoxic, and antiviral compounds of 
pharmacological interest. For this purpose, 181 samples of macroalgae 
were evaluated against various microorganisms (bacteria and yeasts), 
cell lines (VERO, KB, and L1210), and herpes simplex virus HSV-1 [8]. 
Without a doubt, this expedition opened a window of opportunity into 
the study of novel molecules. Even though the coastal marine regions 
from southern California to Baja California Sur and the Gulf of 
California have a collective algal richness of around 900 species, the 
pharmacological or industrial uses of these marine algae have not 
been fully studied. In recent years, the number of bioprospecting 
studies of macroalgae from the Gulf of California and the coasts of Baja 
California Sur has increased. These studies have focused on evaluating 
the antibacterial, anticancer, insecticide, and antifouling properties of 
macroalgae in addition to their ability to inhibit enzymes and their 
possible uses as biofertilizers or biostimulants for plant growth and 
have found promising results [9-16]. Therefore, in the present study, 
an evaluation of the anti-inflammatory activity of marine macroalgae 
extracts was carried out to identify species with great potential. 
MATERIALS AND METHODS 
Algae collection and extracts 
Macroalgae were collected from the subtidal zones of San Juan de la 
Costa and Punta Roca Caimancito, which are located in Bahía de La 
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Paz, Baja California Sur, Mexico (fig. 1). The species of macroalgae 
collected included the rhodophytes Opuntiella californica (15-004), 
Laurencia gardnerii (07-002), Laurencia lajolla (13-003), and 
Gracilaria vermiculophylla (14-023); the phaeophytes Sargassum 
horridum (15-007), Sargassum Sinicola (15-002), Colpomenia 
tuberculata (06-030) and Padina sp. (15-001); and the chlorophytes 
Ulva lactuca (14-014) and Codium fragile (10-001). All species were 
identified by Dr. Rafael Riosmena and Dr. Juan Manuel López Vivas 
from the Phycology laboratory of the Autonomous University of Baja 
California Sur, Mexico. 
 
 
Fig. 1: Algae collection sites in Bahía de La Paz, at the south of Baja California peninsula: 1) San Juan de la Costa and 2) Punta Roca Caimancito 
 
All macroalgae materials were washed with fresh water to remove 
foreign matter and subsequently sun-dried, ground, and stored at -20 °C. 
A total of 300 g of each species was exhaustively macerated with 
100% distilled dichloromethane (CH2Cl2). Subsequently, a second 
maceration with 100% ethanol (EtOH) was performed. Both 
extractions with CH2Cl2
Anti-inflammatory activity  
 and EtOH were performed for nine days, and 
the solvents were replaced every third day. The resulting solution was 
dried at 40 °C in a rotary evaporator under reduced pressure to obtain 
two crude organic extracts of each sample. To obtain the aqueous 
extract, 100 g of dry material that had been previously extracted with 
the organic solvents was used. The extracts were placed in distilled 
water and continuously stirred at room temperature (25 °C) for 4 h. 
The temperature was increased to 80 °C and stirred for an additional 2 
h. The aqueous extracts were centrifuged at 3000 rpm until clarified 
solutions were obtained. Each extract was precipitated with the 
addition of 3 volumes of ethanol. Finally, the precipitate was recovered 
by centrifugation and dried in an electric oven at 50 °C. All the extracts 
were stored at -20 °C until further use. 
Three indirect in vitro methods and one in vivo method were used to 
determine anti-inflammatory activity. In vitro methods consisted of 
1) the membrane protection of red blood cells (HRBCs) against 
hemolysis induced by hypotonicity, 2) the inhibition of heat-induced 
protein denaturation (IDP), and 3) the inhibition of the 
myeloperoxidase (MPO) enzyme. The in vivo method consisted of 
the topical administration of 12-O-Tetradecanoylphorbol-13-acetate 
(TPA), which caused acute edema with leukocyte infiltration. 
Human red blood cell (HRBC) method 
This assay was conducted following the method proposed by 
Chippada [17]. To prepare the HRBC suspension, blood was 
obtained by venipuncture from an apparently healthy donor, a fresh 
blood sample was mixed with an equal volume of sterile Alsever 
solution (2% dextrose, 0.8% sodium citrate, 0.05% citric acid, and 
0.42% sodium chloride in water). The mixture was centrifuged at 
3000 rpm for 10 min, and the cell pellet was recovered by 
decantation and washed three times with an isotonic solution 
(0.85%, pH 7.2). A suspension (10% v/v) with an isotonic solution 
was prepared with the cell pellet. 
The assay mixture contained 1 ml of phosphate buffer (pH 7.4, 0.15 
M), 2 ml of hypotonic saline solution (0.36%), 0.5 ml of the HRBC 
suspension (10% v/v), and 0.5 ml of algal extract (10 μg/ml). All 
extracts were incubated at 37 °C for 30 min and centrifuged. 
Diclofenac sodium (10 μg/ml) was used as a control and distilled 
water was used as a blank. The hemoglobin content in the 
supernatant solution was estimated by reading the sample at 560 
nm in a Spectronic 20D spectrophotometer (Milton Roy, Rochester, 
USA).  
The hemolysis percentage of the HRBC membrane was calculated 
with Eq. (1): 
Hemolysis (%) = (ODsample
ODcontrol
)100, ………………….. Eq. (1) 
Where 𝑂𝐷𝑠𝑎𝑚𝑝𝑙𝑒 and 𝑂𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙 are the optical density of the sample 
and control, respectively. 
The HRBC membrane protection percentage was calculated with Eq. (2): 
Protection (%) = 100 − % hemolysis …………… Eq. (2) 
Inhibition of the protein denaturation method 
The test solution (1 ml) consisted of 0.90 ml of egg albumin (1% w/v 
aqueous solution) and 0.1 ml of the test extract (10 μg/ml). The 
negative control (1 ml) consisted of 0.90 ml of egg albumin (1% w/v 
aqueous solution) and 0.1 ml of distilled water. This negative control 
represented 100% protein denaturation. The positive control (1 ml) 
was prepared with 0.90 ml of distilled water and 0.1 ml of diclofenac 
sodium at a concentration of 10 μg/ml. All solutions were adjusted 
to a pH of 6.3. Samples were incubated at 37 °C and after 20 min, the 
temperature was increased to 57 °C for 30 min. After cooling, 2.5 ml 
of phosphate buffer was added. The samples were read at 416 nm in 
a Spectronic 20D spectrophotometer (Milton Roy). The protein 
denaturation inhibition percentage was calculated according to Eq. 
(3) [18]. 
Inhibition (%) = [100 − (ODextract−ODcontrol)
ODcontrol
]100% …………………. Eq. (3) 
Where 𝑂𝐷𝑒𝑥𝑡𝑟𝑎𝑐𝑡 and 𝑂𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙 are the optical density of the extract 
and control, respectively. 
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TPA-induced mouse ear edema and the evaluation of anti-
inflammatory effects 
The assay was carried out according to the methods described by Young 
[19]. Male CD-1 strain mice with weights between 25–30 g were used for 
the bioassay (n = 3 mice per extract). The mice were supplied by the 
bioterium of the Instituto de Fisiología Celular of the Universidad 
Nacional Autónoma de México (UNAM) and maintained with free access 
to food and water under standard conditions (22±4 °C; 12/12 h 
light/dark cycle) according to the regulations established by the official 
Mexican standard NOM-062-ZOO-1999 and international guidelines. 
Experimental procedures followed the protocol approved by the internal 
Animal Ethics Committee of UNAM (CICUAL-IQ-004-17).  
On both sides of the right ear, 10 µl of ethanolic solution of the TPA 
(2.5 μg/ml) irritant was topically applied. The extracts (1 mg) or the 
reference drug (indomethacin) were diluted in 20 µl of ethanol or 
ethanol/acetone (1:1), respectively, and administered after TPA 
application on both sides of the right ear. The left ear was used as a 
control and only ethanol and the sample solvent [ethanol or 
ethanol/acetone (1:1)] were applied. After 4 h, the animals were 
euthanized in a CO2
Δweight (mg) = [Weight Ear R − WeightEar L] ………………… Eq. (4) 
 chamber. After which, a sample of each ear was 
obtained with a 7-mm diameter punch. The amount of swelling was 
calculated based on the weight difference between the right and left 
ear samples with Eq. (4): 
Where 𝑊𝑒𝑖𝑔ℎ𝑡 𝐸𝑎𝑟 𝑅 is the weight of the treated ear, and 
𝑊𝑒𝑖𝑔ℎ𝑡𝐸𝑎𝑟 𝐿 is the weight of the non-treated ear. 
Anti-inflammatory activity was expressed as the edema inhibition 
percent with Eq. (5) 
edema inhibition (%) = (∆WeightA−∆WeightB
∆WeightA
)100 ……………….. Eq. (5) 
Where A is the edema induced by TPA alone, and B is the edema 
induced by TPA plus sample. 
The mice in this study were maintained according to the regulations 
established in the official Mexican standard (NOM-062-ZOO-1999) and 
international guidelines. Experimental procedures followed the protocol 
approved by the internal Animal Ethics Committee of the Universidad 
Nacional Autónoma de México (UNAM; CICUAL-IQ-004-17).  
Ethics approval 
Myeloperoxidase (MPO) assay 
An evaluation of the activity of the extracts and fractions on the MPO 
enzyme was carried out following the methods described by Bradley 
and Suzuki [20, 21]. The mouse-ear biopsies were crushed with the 
aid of a metal homogenizer for 30 s in 1 ml of phosphate-buffered 
saline (PBS) with 0.5% hexadecyltrimethylammonium bromide 
(HTAB). Subsequently, the samples were frozen and thawed 3 times 
to induce tissue rupture. At the end of this step, the samples were 
centrifuged for 5 min at 12,000 rpm and 4 °C. The supernatant (10 
μl) was taken in quadruplicate and placed in a 96-well plate. A total 
of 10 μl of 0.5% HTAB was used as the target. In each well, 180 μl of 
PBS was added without HTAB, followed by 20 μl of 0.017% H2O2. 
The reaction was initiated by adding 20 μl of 3,3',5,5'-
tetramethylbenzidine (TMB) 18.4 µM and incubated for 5 min at 37 
°C with gentle shaking. After this time, the reaction was stopped by 
adding 20 μl of 2M H2O2
MPO inhibition (%) = (ODTPA−ODsample
ODTPA
)100 ………………. Eq. (6) 
. Enzymatic activity was determined by the 
difference in optical density at 450 nm with Eq. (6). 
Where, 𝑂𝐷𝑇𝑃𝐴 is the optical density of the biopsy with TPA alone, 
and 𝑂𝐷𝑠𝑎𝑚𝑝𝑙𝑒 is the optical density of biopsy with TPA plus sample. 
Phytochemical analysis 
The compound profile of each crude extract was evaluated by thin-
layer chromatography (TLC) on normal phase glass silica gel plates. 
An eluent system of CH2Cl2
Statistical analysis  
: MeOH (9:1) was employed. The plates 
were completely dried to remove excess solvent. Subsequently, they 
were sprayed with developers (table 1) to identify the presence of 
major compounds [22]. 
Multiple comparisons were performed with one-way analyses of 
variance (ANOVA) followed by Dunnett post-hoc tests. Data are 
presented as the mean±standard error of the mean (SEM). P-values 
≤ 0.05 were considered significant. 
RESULTS  
Dichloromethane (CH2Cl2), ethanol (EtOH), and aqueous (H2
In vitro anti-inflammatory activity (HRBC method) 
O) 
extracts were obtained from each species of macroalgae. A total of 
30 extracts were evaluated with in vitro and in vivo assays to 
determine their activity.  
Human red blood cell membrane stabilization was utilized to 
determinate anti-inflammatory activity. Most of the aqueous extracts 
showed a high percentage of red cell membrane protection (>90%), 
except for the Padina sp., L. gardnerii, and U. lactuca extracts, which 
had low activity (<65%; table 1). The dichloromethane extracts from 
the red algae O. californica, L. lajolla, and G. vermiculophylla showed 
the highest protection percentages (>95%) and were similar to that of 
diclofenac sodium (98.5%), which was used as a positive control. The 
membrane protection percentages of the green and brown algae 
extracts generally did not exceed 30%. In general, the ethanol extracts 
were the least active among all extracts, and only two red algae (L. 
lajolla and G. vermiculophylla) and the brown algae of the Sargassum 
genus had activity percentages above 70%. The ethanol extracts of O. 
californica and C. fragile did not present activity and allowed for 
complete membrane lysis (table 1). 
Inhibition of protein denaturation  
The aqueous extract of G. vermiculophylla presented the highest 
inhibitory effect (85%) on protein denaturation at a concentration of 
10 μg/ml compared to those of the other extracts (table 1). At the 
same concentration with diclofenac sodium, 96% inhibition was 
obtained. The other aqueous extracts with activity were from Padina 
sp., C. tuberculata, and L. gardnerii, with activities of 31, 17, and 10%, 
respectively. The dichloromethane extracts of the red algae G. 
vermiculophylla, L. gardnerii, and O. californica presented 54, 49, and 
30% protection of the protein structures, respectively. The rest of the 
algae extracts did not inhibit protein denaturation. In general, the 
ethanol extracts conferred low protein structure protection, with L. 
gardneri, C. fragile, and Padina sp. showing the highest denaturation 
inhibition percentages of 47, 30, and 28%, respectively. 
TPA-induced edema mouse ear  assay and anti-inflammatory effects 
The topical application of TPA induced an increase in ear weight (15.8 
mg) due to edema during the inflammation process. The 
dichloromethane extracts resulted in higher reductions of 
inflammation with edema inhibition percentages between 41 and 
65.7% (fig. 2). The rhodophyte extracts presented the greatest edema 
inhibition (G. vermiculophylla, 65.7%; O. californica, 64.2%). Other 
extracts with good activity were those from the brown algae C. 
tuberculata and the green algae C. fragile with 61.5% and 61.2% 
edema reduction, respectively (fig. 2A). The anti-inflammatory activity 
of the ethanol extracts was low (<35%). The extracts from L. gardneri, 
C. fragile, L. lajolla, and Padina sp. reached edema inhibition values 
between 19 and 22% (fig. 2B). In the case of the aqueous extracts, only 
four of these could be evaluated since total dissolution was not always 
achieved. The aqueous extracts (fig. 3C) showed a minor effect on the 
reduction of mouse ear edema; only the C. tuberculata extract showed 
slightly more than 10% inhibition. Indomethacin was used as a 
positive control and was able to inhibit edema by 82.3%. 
Myeloperoxidase (MPO) activity 
The effects of the macroalgae extracts and indomethacin on MPO 
levels in the TPA-induced mouse ear edema are shown in fig. 3. In 
the TPA treatment group, MPO activity was 100%, while 
indomethacin (positive control) reduced MPO activity by 95%. The 
extracts with the greatest effects on MPO activity in the ear tissues 
were the dichloromethane extracts of G. vermiculophylla and C. 
tuberculata, which caused a 70% reduction in MPO activity, followed 
by the O. californica extract, which caused a reduction in MPO 
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activity of 56% (fig. 3A). The ethanol and aqueous extracts showed 
lower activity compared to those of the other extracts, and most 
active extracts reduced MPO activity by about 50%. The ethanol 
extracts of U. lactuca reduced MPO activity by 56% (fig. 3B), and the 
aqueous extracts of C. tuberculata, G. vermiculophylla, and C. fragile 
inhibited MPO activity by 52–55% (fig. 3B, C). 
 
Table 1: Percentage of in vitro anti-inflammatory activity determined by human red blood cell (HRBC) and heat-induced protein denaturation 
(IDP) of the dichloromethane (CH2Cl2), ethanol (EtOH) and aqueous (H2
 
O) extracts of the macroalgae collected from Bahía de La Paz, B.C.S., 
Mexico 
Extract (10 µg/ml) HRBC (%) IDP (%) 
Rhodophytes    
Opuntiella californica  CH2Cl 95.2±0.00 2 30±2.0 
EtOH NA NA 
H2 98.2±0.00 O NA 
Laurencia gardnerii CH2Cl 15.6±0.19 2 49±2.8 
EtOH 72.1±0.01 9±0.5 
H2 63.2±0.05 O 10±0.9 
Laurencia lajolla CH2Cl 96.6±0.01 2 NA 
EtOH 20.4±0.00 47±2.5 
H2 93.0±0.05 O NA 
Gracilaria vermiculophylla CH2Cl 95.0±0.00 2 54±2.5 
EtOH 77.4±0.01 28±2.0 
H2 93.5±0.05 O 85±3.5 
Phaeophytes    
Sargassum horridum CH2Cl NA 2 NA 
EtOH 70.0±0.01 27±1.5 
H2 92.8±0.03 O NA 
Sargassum sinicola CH2Cl 29.2±0.08 2 NA 
EtOH 77.7±0.01 NA 
H2 96.9±0.05 O NA 
Colpomenia tuberculata CH2Cl NA 2 NA 
EtOH 73.5±0.02 NA 
H2 92.7±0.04 O NA 
Padina sp. CH2Cl 10.7±0.05 2 NA 
EtOH 21.9±0.20 28±1.9 
H2 27.4±0.07 O 31±1.8 
Chlorophytes    
Ulva lactuca CH2Cl NA 2 15±0.5 
EtOH 20.4±0.01 1±0.0 
H2 56.8±0.01 O NA 
Codium fragile CH2Cl 21.1±0.07 2 NA 
EtOH NA 30±1.9 
H2 94.1±0.04 O NA 
Control    
Diclofenac sodium (10µg/ml)  98.6±0.00 96±4.0 
Abbreviations: HRBC, human red blood cell; IDP, inhibition of protein denaturation; NA, no activity. Data are expressed as mean±SEM; n = 3. 
 
 
Fig. 2: Topical anti-inflammatory activity of the macroalgae extracts 
(1 mg/ear). A) Dichloromethane (CH2Cl2), B) ethanol (EtOH), and 
C) aqueous (H2
 
O) extracts. Data are expressed as the mean±SEM; n 
= 3 for ear edema. *P<0.05; compared-to the control. The edema 
inhibition percentage is located above each bar. Abbreviations: 
TPA, 12-tetradecanoylphorbol 13-acetate; IMC, Indomethacin; Oc, 
Opuntiella californica; Lg, Laurencia gardnerii; Ll, Laurencia lajolla; 
Gv, Gracilaria vermiculophylla; Sh, Sargassum horridum; Ss, 
Sargassum sinicola; Ct, Colpomenia tuberculate; Psp, Padina sp.; Ul, 
Ulva lactuca; and Cf, Codium fragile 
Fig. 3: Comparative effect of the macroalgae extracts and 
indomethacin on myeloperoxidase (MPO) levels in TPA-inducted 
ear mouse edema. A) Dichloromethane (CH2Cl2), B) ethanol 
(EtOH), and C) aqueous (H2O) extracts. Data are expressed as 
mean±SEM; n =4 *P<0.05 compared to the control. Abbreviations: 
TPA, 12-tetradecanoylphorbol 13-acetate; IMC, Indomethacin; Oc, 
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Opuntiella californica; Lg, Laurencia gardnerii; Ll, Laurencia lajolla; 
Gv, Gracilaria vermiculophylla; Sh, Sargassum horridum; Ss, 
Sargassum sinicola; Ct, Colpomenia tuberculata; Psp, Padina sp.; Ul, 
Ulva lactuca; and Cf, Codium fragile 
Phytochemical analysis 
Considering the anti-inflammatory activity obtained in the 
different in vitro and in vivo assays, the phytochemical 
characteristics of the extracts with the highest potential are 
summarized in table 2. The principal constituents of the 
macroalgae extracts were flavonoids, terpene-type compounds, 
and alkaloids. Flavonoids were present in almost all extracts 
except for those of C. fragile. Coumarins and phenols were 
absent in most extracts. Coumarins were only detected in G. 
vermiculophylla and C. tuberculata extracts, whereas phenols 
were only detected in L. gardneri and Padina sp. extracts. 
 
Table 2: Phytochemical constituents of seven macroalgae extracts with potential anti-inflammatory activity. Abbreviations: CH2Cl2
Extract 
, 
Dichloromethane; EtOH, Ethanol; Flav, Flavonoids; Ter, Terpenoids; Alk, Alkaloids; Sap, Saponins; Coum, Coumarins 
Phytochemical profile 
Flav Terp Alk Sap Coum Phenols 
Rhodophytes        
Gracilaria vermiculophylla CH2Cl + 2 + - - + - 
Laurencia gardnerii CH2Cl + 2 + - - - + 
Opuntiella califórnica  CH2Cl + 2 + + - - - 
Laurencia lajolla EtOH + - + + - - 
Phaeophytes        
Colpomenia tuberculata CH2Cl + 2 - + - + - 
Padina sp. EtOH + - - + - + 
Chlorophytes        
Codium fragile EtOH - + + + - - 
 
DISCUSSION 
In the search for new marine resources with anti-inflammatory 
properties, bioprospection is necessary, especially in environments 
with high biodiversity that have not been previously evaluated. 
Bioprospection studies can provide new resources that may serve as 
the foundations for novel solutions to health problems [23]. As such, 
the anti-inflammatory potential of the extracts from ten macroalgae 
from Bahía de La Paz, Mexico, was evaluated using in vitro and in 
vivo assays, and the profiles of the chemical constituents in the crude 
extracts were identified. 
The HRCB method is an in vitro assay of the anti-inflammatory 
activity of a drug. The erythrocyte membrane is analogous to the 
lysosomal membrane, this implies that if an extract can stabilize the 
erythrocyte membrane against the effects of hypotonicity, it will also 
be able to stabilize the lysosomal membrane. This stabilization 
prevents the release of lysosomal constituents of activated 
neutrophils, which cause damage and thus limit the inflammatory 
response [24-26]. In this sense, the dichloromethane and ethanol 
extracts of the red algae O. californica, L. lajolla, and G. 
vermiculophylla showed anti-inflammatory properties and exhibited 
>95% membrane protection, suggesting that they possess anti-
inflammatory properties similar to the ones obtained from 
diclofenac sodium (positive control). Although there are no reports 
of erythrocyte membrane stabilization due to hypotonicity, the 
results obtained with organic extracts from rhodophytes are 
comparable to those reported for higher plants. The methanol 
extract of Anisomeles malabarica Linn [18] has been found to have 
the maximum membrane stabilization effect (98.3%) but at a higher 
concentration (2 mg/ml) than the one used in this study (10 µg/ml). 
In other studies, the membrane stabilization percentages were 
lower than the values observed in this study. For example, a 
membrane stabilization percentage of 57.4% was obtained with a 
methanolic extract from Michelia champaca at concentrations 
between 100 and 300 μg/ml, while 63.8% membrane stabilization 
was obtained with an extract based on plant mixtures [27, 28]. With 
regard to the extracts from brown algae, the activity of the aqueous 
extracts of S. horridum, S. sinicola, and C. tuberculata were very 
promising since they showed high stabilization effects (>90%). It 
has been determined that aqueous extracts of brown algae contain 
polyanionic polysaccharides, such as fucoidan and alginates, which 
could be related with this activity [29]. The ethanol extracts of S. 
horridum, S. sinicola, and C. tuberculate showed minor stabilization 
membrane effects compared to those of their aqueous extracts (70–
73%).  
However, these extracts may be very promising, especially when 
compared with the membrane stabilization results obtained with 
the methanolic extract of Sargassum wigthii, which showed values 
between 52 and 54% at concentrations up to 50 μg/ml [30].  
Another cause of inflammation is the denaturation of tissue proteins, 
which can result in the production of autoantigens in certain 
arthritic diseases [31, 32]. The results of this study showed that the 
aqueous extract of G. vermiculophylla (10 μg/ml) had the highest 
protein denaturation inhibitory ability (85%) compared with that of 
diclofenac sodium (96%). This result indicates that this extract could 
have anti-inflammatory and anti-rheumatoid properties [33]. 
Similar effects were obtained for a polyherbal extract with 72.8% 
inhibition and the ethanolic extract of Oryza sativa, a rice species of 
Indian origin, which had an inhibitory effect of 84.2% at a 
concentration of 500 μg/ml [28, 34].  
The TPA-induced ear edema model is commonly used in the search 
for compounds with anti-inflammatory activity and to evaluate the 
activity of mediators, such as leukotrienes, prostaglandins, and 
lysosomal enzymes, and leukocyte migration-degranulation through 
the release of various enzymes like MPO. The topical application of 
TPA induced inflammation with associated edema formation and 
increased MPO activity [35-37]. With regard to antiedematous 
activity, the dichloromethane extracts exhibited the greatest effects 
with respect to the edema inhibition percentage, specifically the 
extracts from the red algae G. vermiculophylla (65.7%), O. californica 
(64.2%), and L. gardnerii (53.1%). A similar study with G. verrucosa 
found promising activity, with 79% ear edema inhibition [38]. In the 
phytochemical analysis, it was observed that the main compounds of 
the red algae used in this study were flavonoids, coumarins, and 
phenols. In addition to histamine release inhibition, cell migration 
inhibition, free radical sequestration, and the vascular protective 
effect, it is known that many flavonoids and phenols act 
synergistically to enhance anti-inflammatory effects, and a possible 
mechanism of action may be the inhibitory activity they exert on 
prostaglandin synthetase [39, 40]. 
With respect to the brown algae in this study, the dichloromethane 
extracts of C. tuberculata (61.2%) and S. sinicola (57.9%) were the 
most active. Khan [39] reported similar results and demonstrated 
that the methanol extracts of Colpomenia bullosa and Colpomenia 
sinuosa inhibited ear mouse edema by 52 and 72%, respectively, at a 
concentration similar to that used in the present study. In the 
phytochemical analysis of brown algae, mainly flavonoid compounds 
were identified. Flavonoids are widely distributed among terrestrial 
(e. g., upper plants) and marine (e. g., macroalgae, sponges, and 
tunicates) organisms [38, 41]. This group of compounds has been 
widely studied and diverse pharmacological properties have been 
attributed to this group, such as antiviral, antibacterial, 
neuroprotective, and anti-inflammatory activities [42-45]. 
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Antioxidant effects, metal chelation, enzymatic inhibition, and gene 
regulation are among the mechanisms that have been proposed to 
explain the biological activities of these compounds [46]. 
Specifically, the anti-inflammatory activity of flavonoids has been 
found to result from the combination of iron-chelating properties 
and free radical scavengers in addition to the inhibition of oxidases, 
such as lipoxygenase, cyclooxygenase, myeloperoxidase, NADPH 
oxidase, and xanthine oxidase [47]. Other mechanisms could also 
include the inhibition of enzymes involved in oxidative processes, 
such as phospholipase A2, and the stimulation of other enzymes 
with antioxidant properties, such as catalase and superoxide 
dismutase [48]. Other compounds like the polysaccharides obtained 
from Lobophora variegata have been found to reduce edema 
induced in rat legs by up to 44% [30, 38]. 
The extracts from the green algae group had low anti-inflammatory 
activity, and only the aqueous extract from C. fragile managed to 
protect erythrocyte membranes against induced hemolysis. In the in 
vivo assay, the dichloromethane extract of C. fragile inhibited ear 
edema up to 61% and the activity of the MPO enzyme by 50%. The 
activity of the C. fragile dichloromethane extract was higher than 
that of a methanol extract from C. fragile collected from the Korean 
coast, which barely exceeded 30% activity [38]. In other green algae, 
better results have been observed than those of our study. For 
example, a methanol extract of U. lactuca achieved an edema 
reduction of up to 80% at a concentration of 500 mg/kg [49].  
The red algae group is considered to be the most important source 
of biologically active compounds when compared to the brown and 
green algae groups [4]. The results of the present study indicated 
that the most active extracts were the dichloromethane extracts of G. 
vermiculophylla and O. californica. These extracts showed membrane 
protective capacity values that reached ~ 90%. In the in vivo assay, 
these extracts exhibited an evident reduction in edema and MPO 
activity. The phytochemical analysis indicated that alkaloid-type 
compounds, coumarins, flavonoids, and phenols were present in the 
extracts. Similar results were observed with dichloromethane 
extracts from Cryptostegia grandiflora, and the authors suggested 
that structurally diverse compounds with different molecular 
mechanisms that could enhance anti-inflammatory properties were 
present in the extracts [37]. Secondary metabolites of different 
chemical natures and anti-inflammatory activity have been 
identified with various experimental models and have been isolated 
from rhodophytes, notably amino acids, peptides, proteins, steroids, 
terpenes, lipids, and phenols [50-54]. 
Taking into consideration the results of the in vitro and in vivo 
assays, the two species that presented the greatest potential anti-
inflammatory activity were G. vermiculophylla and O. californica. 
Gracilaria vermiculophylla is known to be capable of producing 
compounds with anti-inflammatory activity [55, 56]. However, this 
is the first study to report the anti-inflammatory activity of extracts 
from the brown macroalgae O. californica, the results of which are 
very promising. This group of brown macroalgae (Phaeophyceae) 
are rich in polyphenols and phlorotannins, and some are used in 
medicine as their anti-inflammatory activity [57, 58]. 
In this study, the compounds responsible for anti-inflammatory 
activity were not isolated, but the qualitative phytochemical was 
described, although the presence of a certain type of metabolite 
depends on the solvent used in the extraction and the properties of 
the species, phytochemical analyzes reveal valuable information 
[59]. Previous studies have reported that seaweeds carry out the 
biosynthesis of alkaloids, phenols, and flavonoids with similar 
chemical structures to those of anti-inflammatory drugs. Such is the 
case with caulerpine, which is a bisindole alkaloid that contains two 
indole groups (benzylpirroles derived from tryptophan) that are 
linked by a cyclic 8-carbon ring with two carboxyl groups, which 
presents anti-inflammatory activity. Caulerpine has been isolated 
from several species of green and red algae and is structurally 
similar to indomethacin (indole alkaloid nucleus), which is one of 
the most commonly used drugs to treat inflammation [60, 61]. 
Paracetamol is para-aminophenolic and is used as an analgesic and 
anti-inflammatory compound. Paracetamol is structurally analogous 
to the amides synthesized by some red algae, such as benzamide and 
benzenoacetamide [62]. On the other hand, the ability of 
rhodophytes to synthesize phenolic compounds that show anti-
inflammatory activity via FLAT2 inhibition such as the 
bromophenols isolated from Vidalia obtusaloba (e. g., viadol A and B) 
has been recognized due to TPA-induced atrial edema [63]. Another 
commonly used drug to control inflammatory processes is 
diclofenac sodium, a derivative of phenylacetic acid. Rhodophytes 
are capable of synthesizing acetic acid-derived compounds, such as 
indoleacetic acid and indocarboxylic acid, which have chemical 
structures that are similar to that of diclofenac sodium [64].  
CONCLUSION 
The bioprospection of several macroalgae species from Bahía de La 
Paz, Mexico, permitted the identification of two species that showed 
promising anti-inflammatory activity. Gracilaria vermiculophylla 
showed interesting topical anti-inflammatory effects and compound 
profiles that may contribute to the biological properties of this 
seaweed. This is the first study to report the anti-inflammatory 
activity of Opuntiella californica, and the results regarding both cell 
membrane protection and topical effects are very promising. The 
compound profile of these seaweeds indicated the presence of 
flavonoids, alkaloids, and terpene-type compounds. Additional 
research is needed to identify the compounds responsible for the 
anti-inflammatory activities observed in this study in order to offer 
and cultivate alternative phytopharmaceuticals.  
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